Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 48
16
Diseases
22
Unique genes
0.233
Avg. similarity score
Polycystic kidney disease with tuberous sclerosis
Most-connected disease (7 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Polycystic kidney disease with tuberous sclerosis
Adenomatous polyposis
Polycystic kidneys, severe infantile with tuberous sclerosis
Congenital kidney anomaly
Focal cortical dysplasia
Tuberous sclerosis complex
Liver cyst
Renovascular hypertension
Xanthinuria
Encephalocele
NTHL1-deficiency tumor predisposition syndrome
CEP290-related ciliopathy
Folic acid deficiency
familial adenomatous polyposis 4
joubert syndrome 17
xanthinuria type II
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Polycystic kidney disease with tuberous sclerosis | 7 | 7 | 2 |
| Adenomatous polyposis | 6 | 6 | 6 |
| Polycystic kidneys, severe infantile with tuberous sclerosis | 6 | 6 | 2 |
| Congenital kidney anomaly | 5 | 5 | 3 |
| Focal cortical dysplasia | 5 | 5 | 7 |
| Tuberous sclerosis complex | 5 | 5 | 6 |
| Liver cyst | 4 | 4 | 1 |
| Renovascular hypertension | 4 | 4 | 2 |
| Xanthinuria | 4 | 4 | 4 |
| Encephalocele | 3 | 3 | 4 |
| NTHL1-deficiency tumor predisposition syndrome | 3 | 3 | 1 |
| CEP290-related ciliopathy | 2 | 2 | 1 |
| Folic acid deficiency | 1 | 1 | 1 |
| familial adenomatous polyposis 4 | 1 | 1 | 1 |
| joubert syndrome 17 | 1 | 1 | 1 |
| xanthinuria type II | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| PKD1 | 7 / 16 | Congenital kidney anomaly, Focal cortical dysplasia, Liver cyst, Polycystic kidney disease with tuberous sclerosis and 3 more |
| TSC2 | 6 / 16 | Adenomatous polyposis, Focal cortical dysplasia, Polycystic kidney disease with tuberous sclerosis, Polycystic kidneys, severe infantile with tuberous sclerosis and 2 more |
| NTHL1 | 4 / 16 | Adenomatous polyposis, Focal cortical dysplasia, NTHL1-deficiency tumor predisposition syndrome, Tuberous sclerosis complex |
| CEP290 | 3 / 16 | CEP290-related ciliopathy, Congenital kidney anomaly, Encephalocele |
| CPLANE1 | 2 / 16 | Encephalocele, joubert syndrome 17 |
| DHFR | 2 / 16 | Adenomatous polyposis, Folic acid deficiency |
| MOCOS | 2 / 16 | Xanthinuria, xanthinuria type II |
| MSH3 | 2 / 16 | Adenomatous polyposis, familial adenomatous polyposis 4 |
| TSC1 | 2 / 16 | Focal cortical dysplasia, Tuberous sclerosis complex |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Energy dependent regulation of mTOR by LKB1-AMPK | Reactome | 4 / 29 | 75.3× | 1.95e-7 | 1.17e-5 ✓ sig. |
| Macroautophagy | Reactome | 4 / 68 | 32.1× | 6.37e-6 | 2.29e-4 ✓ sig. |
| Inhibition of TSC complex formation by PKB | Reactome | 2 / 3 | 364× | 9.60e-6 | 3.25e-4 ✓ sig. |
| Herpes simplex virus 1 infection | KEGG | 5 / 182 | 15.0× | 1.62e-5 | 5.00e-4 ✓ sig. |
| TP53 Regulates Metabolic Genes | Reactome | 4 / 86 | 25.4× | 1.62e-5 | 5.03e-4 ✓ sig. |
| Longevity regulating pathway | KEGG | 4 / 90 | 24.3× | 1.95e-5 | 5.86e-4 ✓ sig. |
| Choline metabolism in cancer | KEGG | 4 / 99 | 22.1× | 2.84e-5 | 7.95e-4 ✓ sig. |
| AMPK signaling pathway | KEGG | 4 / 122 | 17.9× | 6.44e-5 | 1.57e-3 ✓ sig. |
| Insulin signaling pathway | KEGG | 4 / 138 | 15.8× | 1.04e-4 | 2.33e-3 ✓ sig. |
| Displacement of DNA glycosylase by APEX1 | Reactome | 2 / 9 | 121× | 1.14e-4 | 2.50e-3 ✓ sig. |
| Amino acids regulate mTORC1 | Reactome | 3 / 55 | 29.8× | 1.32e-4 | 2.80e-3 ✓ sig. |
| Phospholipase D signaling pathway | KEGG | 4 / 149 | 14.7× | 1.40e-4 | 2.94e-3 ✓ sig. |
| Cellular senescence | KEGG | 4 / 157 | 13.9× | 1.71e-4 | 3.46e-3 ✓ sig. |
| mTOR signaling pathway | KEGG | 4 / 158 | 13.8× | 1.75e-4 | 3.52e-3 ✓ sig. |
| Autophagy - animal | KEGG | 4 / 169 | 12.9× | 2.27e-4 | 4.33e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| TORC1 signaling | GO:0038202 | 4 / 67 | 50.7× | 1.05e-6 | 8.63e-5 ✓ sig. |
| negative regulation of TORC1 signaling | GO:1904262 | 4 / 71 | 47.9× | 1.33e-6 | 1.04e-4 ✓ sig. |
| positive regulation of TORC1 signaling | GO:1904263 | 4 / 71 | 47.9× | 1.33e-6 | 1.04e-4 ✓ sig. |
| cell projection organization | GO:0030030 | 5 / 214 | 19.8× | 4.22e-6 | 2.62e-4 ✓ sig. |
| positive regulation of translational initiation | GO:0045948 | 3 / 42 | 60.7× | 1.58e-5 | 7.48e-4 ✓ sig. |
| negative regulation of translational initiation | GO:0045947 | 3 / 44 | 57.9× | 1.82e-5 | 8.32e-4 ✓ sig. |
| kidney development | GO:0001822 | 4 / 146 | 23.3× | 2.34e-5 | 1.01e-3 ✓ sig. |
| response to fluid shear stress | GO:0034405 | 2 / 8 | 212× | 3.69e-5 | 1.43e-3 ✓ sig. |
| regulation of macroautophagy | GO:0016241 | 3 / 57 | 44.7× | 3.98e-5 | 1.51e-3 ✓ sig. |
| negative regulation of cell size | GO:0045792 | 2 / 9 | 189× | 4.74e-5 | 1.73e-3 ✓ sig. |
| anoikis | GO:0043276 | 2 / 12 | 142× | 8.67e-5 | 2.72e-3 ✓ sig. |
| response to nutrient levels | GO:0031667 | 3 / 79 | 32.3× | 1.06e-4 | 3.15e-3 ✓ sig. |
| negative regulation of macroautophagy | GO:0016242 | 2 / 14 | 121× | 1.19e-4 | 3.46e-3 ✓ sig. |
| cellular response to nutrient levels | GO:0031669 | 3 / 83 | 30.7× | 1.22e-4 | 3.52e-3 ✓ sig. |
| neural tube closure | GO:0001843 | 3 / 85 | 30.0× | 1.31e-4 | 3.71e-3 ✓ sig. |